Welltower (NYSE: WELL) leaders elaborated on the company's major expansion in the U.K., following its acquisition of a ...

While the Presidency is today associated with wealth and fame, many early U.S. Presidents came from humble backgrounds and ...

With Credit blowups pressuring markets, we'll now see the typical dynamic where news/analysis follows market direction. Read ...

Ison has always loved fitness and dance, but she didn’t take up boxing until she was 50. Now the 62-year-old social media ...

DS-3939 is a specifically engineered, potential first-in-class tumor-associated mucin-1 (TA-MUC1) directed DXd antibody drug conjugate (ADC) discovered and being developed by Daiichi Sankyo (TSE: 4568 ...

Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.83, expectations were $9.65. Operator: Welcome to the Regeneron ...

Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in ...

Harbaji, W. and Forawi, S. (2025) The Role of Physical Activity Programs in Combating Childhood Obesity: Insights from Physical Education Teachers at a Private School in Abu Dhabi, UAE. Creative ...

Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the third quarter ended ...

This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...

Robust balance sheet with access to over A$86.3M in funding comprising of, A$17.5M in cash, US$43.4M (A$65.5M) 24 month award from the U.S. Department of War to support antimony production in Alaska, ...